药靶抗体
选项
-
Nemolizumab (anti-IL-31Ra)关联靶标: IL31RA
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG2
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1476039-58-3 -
Rovelizumab (anti-CD11a&CD18)
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG4
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 339086-79-2SMILES: [Rovelizumab] -
Efalizumab (anti-ITGAL)关联靶标: ITGAL
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 恒河猴(Rhesus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 214745-43-4 -
Litifilimab (anti-CLEC4C)关联靶标: CLEC4C
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 2407378-48-5